node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ABK69790.1 | ABK72460.1 | MSMEG_5922 | MSMEG_5921 | Lipid-transfer protein. | Conserved hypothetical protein; Identified by match to protein family HMM PF01796. | 0.994 |
ABK69790.1 | ABK74398.1 | MSMEG_5922 | MSMEG_5924 | Lipid-transfer protein. | Conserved hypothetical protein. | 0.476 |
ABK69790.1 | ABK75469.1 | MSMEG_5922 | MSMEG_5923 | Lipid-transfer protein. | acetyl-CoA acetyltransferase. | 0.961 |
ABK69790.1 | ABK75998.1 | MSMEG_5922 | MSMEG_5927 | Lipid-transfer protein. | Conserved hypothetical protein. | 0.767 |
ABK69790.1 | kshA | MSMEG_5922 | MSMEG_5925 | Lipid-transfer protein. | Rieske [2Fe-2S] domain protein; Involved in the degradation of cholesterol. Catalyzes the introduction of a 9a-hydroxyl moiety into 1,4-androstadiene-3,17-dione (ADD) to yield the 9alpha-hydroxy-1,4-androstadiene-3,17-dione (9OHADD) intermediate which spontaneously form 3-hydroxy-9,10-seconandrost- 1,3,5(10)-triene-9,17-dione (HSA) via the meta-cleavage of ring B with concomitant aromatization of ring A. | 0.843 |
ABK72460.1 | ABK69790.1 | MSMEG_5921 | MSMEG_5922 | Conserved hypothetical protein; Identified by match to protein family HMM PF01796. | Lipid-transfer protein. | 0.994 |
ABK72460.1 | ABK74398.1 | MSMEG_5921 | MSMEG_5924 | Conserved hypothetical protein; Identified by match to protein family HMM PF01796. | Conserved hypothetical protein. | 0.400 |
ABK72460.1 | ABK75469.1 | MSMEG_5921 | MSMEG_5923 | Conserved hypothetical protein; Identified by match to protein family HMM PF01796. | acetyl-CoA acetyltransferase. | 0.996 |
ABK72460.1 | ABK75998.1 | MSMEG_5921 | MSMEG_5927 | Conserved hypothetical protein; Identified by match to protein family HMM PF01796. | Conserved hypothetical protein. | 0.829 |
ABK72460.1 | kshA | MSMEG_5921 | MSMEG_5925 | Conserved hypothetical protein; Identified by match to protein family HMM PF01796. | Rieske [2Fe-2S] domain protein; Involved in the degradation of cholesterol. Catalyzes the introduction of a 9a-hydroxyl moiety into 1,4-androstadiene-3,17-dione (ADD) to yield the 9alpha-hydroxy-1,4-androstadiene-3,17-dione (9OHADD) intermediate which spontaneously form 3-hydroxy-9,10-seconandrost- 1,3,5(10)-triene-9,17-dione (HSA) via the meta-cleavage of ring B with concomitant aromatization of ring A. | 0.838 |
ABK74398.1 | ABK69790.1 | MSMEG_5924 | MSMEG_5922 | Conserved hypothetical protein. | Lipid-transfer protein. | 0.476 |
ABK74398.1 | ABK72460.1 | MSMEG_5924 | MSMEG_5921 | Conserved hypothetical protein. | Conserved hypothetical protein; Identified by match to protein family HMM PF01796. | 0.400 |
ABK74398.1 | ABK75469.1 | MSMEG_5924 | MSMEG_5923 | Conserved hypothetical protein. | acetyl-CoA acetyltransferase. | 0.474 |
ABK74398.1 | ABK75998.1 | MSMEG_5924 | MSMEG_5927 | Conserved hypothetical protein. | Conserved hypothetical protein. | 0.525 |
ABK74398.1 | kshA | MSMEG_5924 | MSMEG_5925 | Conserved hypothetical protein. | Rieske [2Fe-2S] domain protein; Involved in the degradation of cholesterol. Catalyzes the introduction of a 9a-hydroxyl moiety into 1,4-androstadiene-3,17-dione (ADD) to yield the 9alpha-hydroxy-1,4-androstadiene-3,17-dione (9OHADD) intermediate which spontaneously form 3-hydroxy-9,10-seconandrost- 1,3,5(10)-triene-9,17-dione (HSA) via the meta-cleavage of ring B with concomitant aromatization of ring A. | 0.525 |
ABK75469.1 | ABK69790.1 | MSMEG_5923 | MSMEG_5922 | acetyl-CoA acetyltransferase. | Lipid-transfer protein. | 0.961 |
ABK75469.1 | ABK72460.1 | MSMEG_5923 | MSMEG_5921 | acetyl-CoA acetyltransferase. | Conserved hypothetical protein; Identified by match to protein family HMM PF01796. | 0.996 |
ABK75469.1 | ABK74398.1 | MSMEG_5923 | MSMEG_5924 | acetyl-CoA acetyltransferase. | Conserved hypothetical protein. | 0.474 |
ABK75469.1 | ABK75998.1 | MSMEG_5923 | MSMEG_5927 | acetyl-CoA acetyltransferase. | Conserved hypothetical protein. | 0.624 |
ABK75469.1 | kshA | MSMEG_5923 | MSMEG_5925 | acetyl-CoA acetyltransferase. | Rieske [2Fe-2S] domain protein; Involved in the degradation of cholesterol. Catalyzes the introduction of a 9a-hydroxyl moiety into 1,4-androstadiene-3,17-dione (ADD) to yield the 9alpha-hydroxy-1,4-androstadiene-3,17-dione (9OHADD) intermediate which spontaneously form 3-hydroxy-9,10-seconandrost- 1,3,5(10)-triene-9,17-dione (HSA) via the meta-cleavage of ring B with concomitant aromatization of ring A. | 0.809 |